35 results
8-K/A
EX-10.1
ARAV
Aravive Inc
28 Oct 22
Other Events
4:05pm
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
8-K
EX-10.1
ARAV
Aravive Inc
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
8-K
EX-10.1
ARAV
Aravive Inc
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
8-K
EX-10.2
ARAV
Aravive Inc
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising
8-K
EX-10.1
4ybou9esab 0lo
10 Nov 20
Entry into a Material Definitive Agreement
7:10am
S-4
z359v05kbrg5lbgqp27
3 Aug 18
Registration of securities issued in business combination transactions
5:26pm
S-4
EX-10.6
jw09zrpw
3 Aug 18
Registration of securities issued in business combination transactions
5:26pm